Dr. Evan Appelbaum, MD

Dr. Appelbaum practices at Men's Health Boston in Chestnut Hill, Massachusetts.

Dr. Appelbaum's NPI, 1346349669, was assigned on September 22, 2006. Dr. Appelbaum graduated from Tel Aviv University Sackler in 1997. Dr. Appelbaum holds Massachusetts license 210381.

Dr. Appelbaum's primary practice is Men's Health Boston, at 200 Boylston St A309, Chestnut Hill, MA 02467-2012. The practice phone is (617) 277-5000.

Dr. Appelbaum's primary practice is Men's Health Boston in Chestnut Hill, Massachusetts. Dr. Appelbaum is also affiliated with Brigham and Women's Hospital. The medical group on file is Men's Health Boston. Dmand AI also links Dr. Appelbaum to 4 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Appelbaum practices, 8 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Appelbaum's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Appelbaum is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Appelbaum's licenses on file in 3 states: Massachusetts, Montana and New York.

Dmand AI lists aneurysm, atrial fibrillation and flutter, cardiomyopathy, cerebrovascular disease, chronic hypertension, coronary artery disease, deep vein thrombosis (DVT) and heart blockage among the conditions Dr. Appelbaum treats.

CMS data shows 283,345 Medicare services from Dr. Appelbaum across 31 procedure codes in 2024, for 730 Medicare patients. Medicare paid $552,298 for them. Every service was in an office.

CMS counts 730 Medicare patients who saw Dr. Appelbaum in 2024. The largest group is 65 to 74, with 340 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 5% are also on Medicaid. Their average risk score is 0.96, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Appelbaum's median patient age at 61, with 16% women.

In 2024, Dr. Appelbaum wrote 3,195 Medicare Part D claims for 520 patients. 84% of them were for generic drugs. CMS names the drug for 2,914 of them, across 37 drugs with 11 or more claims each, at $471,423 in total drug cost. In 2023, CMS named 3,054 claims across 42 drugs.

Dr. Appelbaum accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Appelbaum as offering telehealth.

Dmand AI links 45 papers to Dr. Appelbaum, published from 2007 to 2024. 2012 was the busiest year, with 4. The most frequent topics are Magnetic Resonance Imaging, Cardiomyopathy, Hypertrophic and Magnetic Resonance Imaging, Cine. Dr. Appelbaum has published most often in Am J Cardiol. Dr. Appelbaum's most frequent co-authors are Martin S. Maron, MD, Charles M. Gibson, MD and Rajiv Agarwal, MD.

CMS Open Payments shows 341 general payments to Dr. Appelbaum from 40 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 85% of the total. AstraZeneca Pharmaceuticals LP paid the most, $43,366. It also lists 3 research payments totaling $6,400 from 2019 to 2020.

Dmand AI lists 1 award for Dr. Appelbaum, most recently CMS Stage 1 2012 in 2011.

Dr. Appelbaum graduated from Tel Aviv University Sackler in 1997.

Dr. Appelbaum is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.